monensin

Monensin sodium is an antiprotozoal agent produced by Streptomyces cinnamonensis.Monensin sodium salt (Monensin A sodium salt) causes a marked enlargement of the MVBs and regulates exosome secretion

Monensin is an antiprotozoal agent produced by Streptomyces cinnamonensis. It has an inhibitory effect on the Wnt β-catenin signaling cascade. Monensin is a prospective anticancer drug for the therapy of neoplasia with deregulated Wnt signaling.

Monensin B is a polyketide compound derived from the bacterium Streptomyces cinnamonensis. Its production involves the fermentation of Streptomyces cinnamonensis, resulting in a mixture of Monensin A and Monensin B. The ratio of these two compounds depends on the concentrations of ethylmalonyl-CoA and methylmalonyl-CoA.

Monensin sodium salt (Standard) is the standard substance of Monensin sodium salt, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Monensin sodium is an antiprotozoal agent produced by Streptomyces cinnamonensis.Monensin sodium salt (Monensin A sodium salt) causes a marked enlargement of the MVBs and regulates exosome secretion

Monensin C is an oxygenated heterocyclic polyether antibiotic. It exhibits activity against bacteria, mycobacteria, fungi, and protozoa, though it is less effective against Gram-negative bacteria. Additionally, it shows inhibitory effects on HeLa cells.

3-O-Demethylmonensin A is a polyether antibiotic produced by Streptomyces cinnamonensis (strain LO-63).

3-O-Demethylmonensin B is a polyether antibiotic produced by the bacterium *Streptomyces cinnamoneus* LO-63.

Fudecalone is produced by the Penicillium strain FO-2030. It completely inhibits the coccidian parasite Eimeria Tenella that is resistant to Monensin.